Illumina Inc Net Income per Employee (ILMN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Illumina Inc   (NASDAQ: ILMN)
 

Illumina Inc Net Income per Employee

ILMN's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 46.67% in the third quarter 2026, year on year to cumulative value of $895 million, and with 1,280 employees, Illumina Inc 's income per employee grew on trailing twelve month basis to $ 699,219. The income per employee at Illumina Inc ' was above the company average.
The Healthcare sector has seen Illumina Inc achieved the highest income per employee. While Illumina Inc 's total ranking has deteriorated compared to the previous quarter from 263 to 265.


What is Income per Employee Ratio?






ILMN Net Income per Employee (Sep 27 2026)
III. Quarter
(Jun 28 2026)
II. Quarter
(Mar 29 2026)
I. Quarter
(Dec 28 2025)
IV. Quarter
(Sep 28 2025)
III. Quarter
Y / Y Net Income Change 46.67 % -11.91 % 2.29 % 79.57 % -78.72 %
Net Income per Employee (TTM) $ 699,219 644,531 666,406 664,063 548,438
ILMN's Total Ranking # 265 # 263 # 446 # 1053 #
Seq. Net Income Change 6.28 % 54.48 % -59.88 % 122.67 % -36.17 %


ILMN Net Income per Employee Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 38
Overall Market # 265

Net Income per Employee Statistics
High Average Low
$ 982,031 $ -17,678 $ -3,505,469
(Jun 29 2025)   (Apr 02 2023)







Companies with similar Income per Employee for 12 month ending Sep 27 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 27 2026Number of Employees Sep 27 2026
Ligand Pharmaceuticals Incorporated  1,094,936.17 $ 51.462  Million 47 
Alnylam Pharmaceuticals Inc   1,089,695.60 $ 2,724.239  Million 2,500 
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 
Illumina Inc   699,218.75 $ 895.000  Million 1,280 
Black Hawk Acquisition Corporation  649,852.50 $ 1.300  Million 2 
Eli Lilly And Company  551,594.00 $ 27,579.700  Million 50,000 
Indivior Pharmaceuticals Inc   451,000.00 $ 451.000  Million 1,000 
Denali Therapeutics Inc   393,667.99 $ 198.015  Million 503 
Neurocrine Biosciences Inc   351,250.00 $ 702.500  Million 2,000 


Date modified: 2026-10-31T09:55:44+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.